{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T01:44:41Z","timestamp":1791769481271,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K09880"],"award-info":[{"award-number":["18K09880"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61752-8","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T09:54:53Z","timestamp":1783763693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lactobacillus reuteri lozenges and chemotherapy-induced oral mucositis in breast cancer outpatients: an exploratory randomized controlled trial"],"prefix":"10.1038","volume":"16","author":[{"given":"Hiromi","family":"Nishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Horikoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Sasada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Shigeishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marino","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Nakaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Shigematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Kakimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ohge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"61752_CR1","first-page":"lgz011","volume":"53","author":"RV Lalla","year":"2019","unstructured":"Lalla, R. V. et al. Oral mucositis due to high-dose chemotherapy and\/or head and neck radiation therapy. J. Natl. Cancer Inst. Monogr. 53, lgz011 (2019).","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"61752_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01715-7","volume":"39","author":"C Pulito","year":"2020","unstructured":"Pulito, C. et al. Oral mucositis: The hidden side of cancer therapy. J. Exp. Clin. Cancer Res. 39, 210 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"61752_CR3","doi-asserted-by":"publisher","first-page":"lgz010","DOI":"10.1093\/jncimonographs\/lgz010","volume":"2019","author":"LS Elting","year":"2019","unstructured":"Elting, L. S. & Chang, Y.-C. Costs of oral complications of cancer therapies: Estimates and a blueprint for future study. J. Natl. Cancer Inst. Monogr. 2019, lgz010 (2019).","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"61752_CR4","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1002\/cncr.33100","volume":"126","author":"S Elad","year":"2020","unstructured":"Elad, S. et al. MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 126, 4423\u20134431 (2020).","journal-title":"Cancer"},{"key":"61752_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08690-1","volume":"32","author":"JE Raber-Durlacher","year":"2024","unstructured":"Raber-Durlacher, J. E. et al. MASCC\/ISOO clinical practice statement: Current understanding on controversies in basic oral care in hemato-oncology and hematopoietic cell transplantation. Support Care Cancer 32, 550 (2024).","journal-title":"Support Care Cancer"},{"key":"61752_CR6","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1007\/s00520-019-04848-4","volume":"27","author":"CHL Hong","year":"2019","unstructured":"Hong, C. H. L. et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 27, 3949\u20133967 (2019).","journal-title":"Support Care Cancer"},{"key":"61752_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-024-04955-7","volume":"24","author":"B Yang","year":"2024","unstructured":"Yang, B., Li, W. & Shi, J. Preventive effect of probiotics on oral mucositis induced by anticancer therapy: A systematic review and meta-analysis of randomized controlled trials. BMC Oral Health 24, 1159 (2024).","journal-title":"BMC Oral Health"},{"key":"61752_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.106785","volume":"193","author":"P Lin","year":"2024","unstructured":"Lin, P. et al. Efficacy of probiotics in the treatment of oral mucositis in head and neck cancer patients: A systematic review and meta-analysis. Microb. Pathog. 193, 106785 (2024).","journal-title":"Microb. Pathog."},{"key":"61752_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00520-024-08733-7","volume":"32","author":"Y Saito","year":"2024","unstructured":"Saito, Y., Takekuma, Y., Takahashi, M., Oshino, T. & Sugawara, M. Association of oral mucositis induced by anthracycline-cyclophosphamide and subsequent docetaxel treatment for perioperative breast cancer. Support Care Cancer 32, 513 (2024).","journal-title":"Support Care Cancer"},{"key":"61752_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16935-4","volume":"12","author":"Y Saito","year":"2022","unstructured":"Saito, Y., Takekuma, Y., Takeshita, T., Oshino, T. & Sugawara, M. Impact of systemic dexamethasone administration on oral mucositis induced by anthracycline-containing regimens in breast cancer treatment. Sci. Rep. 12, 12587 (2022).","journal-title":"Sci. Rep."},{"key":"61752_CR11","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/jcpe.12155","volume":"40","author":"W Teughels","year":"2013","unstructured":"Teughels, W. et al. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: A randomized placebo-controlled study. J. Clin. Periodontol. 40, 1025\u20131035 (2013).","journal-title":"J. Clin. Periodontol."},{"key":"61752_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-019-0679-5","volume":"7","author":"B-Y Hong","year":"2019","unstructured":"Hong, B.-Y. et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome 7, 66 (2019).","journal-title":"Microbiome"},{"key":"61752_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2024.1461463","volume":"5","author":"JAEM Zecha","year":"2024","unstructured":"Zecha, J. A. E. M. et al. Oral microbial changes, oral mucositis and febrile neutropenia during myelosuppressive chemotherapy in patients diagnosed with a solid tumor or lymphoma. Front. Oral Health 5, 1461463 (2024).","journal-title":"Front. Oral Health"},{"key":"61752_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073636","volume":"23","author":"A Buonacera","year":"2022","unstructured":"Buonacera, A., Stancanelli, B., Colaci, M. & Malatino, L. Neutrophil to lymphocyte ratio: An emerging marker of the relationships between the immune system and diseases. Int. J. Mol. Sci. 23, 3636 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"61752_CR15","doi-asserted-by":"publisher","first-page":"102675","DOI":"10.1016\/j.eclinm.2024.102675","volume":"73","author":"R Abdalla-Aslan","year":"2024","unstructured":"Abdalla-Aslan, R. et al. Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: An international Delphi study. eClinicalMedicine 73, 102675 (2024).","journal-title":"eClinicalMedicine"},{"key":"61752_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-023-03356-6","volume":"23","author":"H Nishi","year":"2023","unstructured":"Nishi, H. et al. Head and neck cancer patients show poor oral health as compared to those with other types of cancer. BMC Oral Health 23, 647 (2023).","journal-title":"BMC Oral Health"},{"key":"61752_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/jjco\/hyw077","volume":"46","author":"N Niikura","year":"2016","unstructured":"Niikura, N. et al. Evaluation of oral care to prevent oral mucositis in estrogen receptor-positive metastatic breast cancer patients treated with everolimus (Oral Care-BC): Randomized controlled phase III trial. Jpn. J. Clin. Oncol. 46, 879\u2013882 (2016).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"61752_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12282-022-01410-9","volume":"30","author":"K Suzuki","year":"2023","unstructured":"Suzuki, K. et al. Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy. Breast Cancer 30, 151\u2013155 (2023).","journal-title":"Breast Cancer"},{"key":"61752_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1200\/JOP.19.00652","volume":"16","author":"TJ Brown","year":"2020","unstructured":"Brown, T. J. & Gupta, A. Management of cancer therapy-associated oral mucositis. JCO Oncol. Pract. 16, 103\u2013109 (2020).","journal-title":"JCO Oncol. Pract."},{"key":"61752_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13111603","volume":"13","author":"H Nishi","year":"2023","unstructured":"Nishi, H. et al. Efficacy of low-level laser therapy for oral mucositis in hematologic patients undergoing transplantation: A single-arm prospective study. JPM 13, 1603 (2023).","journal-title":"JPM"},{"key":"61752_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-07989-9","volume":"31","author":"S Oku","year":"2023","unstructured":"Oku, S. et al. Protective effect of cryotherapy against oral mucositis among allogeneic hematopoietic stem cell transplant recipients using melphalan-based conditioning. Support Care Cancer 31, 521 (2023).","journal-title":"Support Care Cancer"},{"key":"61752_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13010045","volume":"13","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. The impact of Lactobacillus reuteri on oral and systemic health: A comprehensive review of recent research. Microorganisms 13, 45 (2024).","journal-title":"Microorganisms"},{"key":"61752_CR23","first-page":"lgz002","volume":"53","author":"CM Jean-Luc","year":"2019","unstructured":"Jean-Luc, C. M., Craig, B. S., Darla, S. M., Michael, T. B. & Farah, B. M. Oral microbiome and cancer therapy-induced oral mucositis. J. Natl. Cancer Inst. Monogr. 53, lgz002 (2019).","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"61752_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3389\/fcimb.2020.00465","volume":"10","author":"MD Ferrer","year":"2020","unstructured":"Ferrer, M. D. et al. Topic application of the probiotic Streptococcus dentisani improves clinical and microbiological parameters associated with oral health. Front. Cell. Infect. Microbiol. 10, 465 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"61752_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1214\/10-AOAS390","volume":"5","author":"M Parzen","year":"2011","unstructured":"Parzen, M. et al. A generalized linear mixed model for longitudinal binary data with a marginal logit link function. Ann. Appl. Stat. 5, 449 (2011).","journal-title":"Ann. Appl. Stat."},{"key":"61752_CR26","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/hed.28020","volume":"47","author":"W Ueangphairot","year":"2025","unstructured":"Ueangphairot, W. et al. Fluconazole for preventing radiation-induced oral mucositis: A randomized controlled trial. Head Neck 47, 1168\u20131175 (2025).","journal-title":"Head Neck"},{"key":"61752_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11040896","volume":"11","author":"R Kullar","year":"2023","unstructured":"Kullar, R., Goldstein, E. J. C., Johnson, S. & McFarland, L. V. Lactobacillus bacteremia and probiotics: A review. Microorganisms 11, 896 (2023).","journal-title":"Microorganisms"},{"key":"61752_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1086\/380455","volume":"38","author":"MK Salminen","year":"2004","unstructured":"Salminen, M. K. et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin. Infect. Dis. 38, 62\u201369 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"61752_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.oor.2025.100759","volume":"15","author":"Z Farivar","year":"2025","unstructured":"Farivar, Z., Salehiniya, H. & Alizadeh, L. Oral care interventions for the prevention and management of anticancer therapy\u2013induced oral mucositis: A systematic review. Oral Oncol. Rep. 15, 100759 (2025).","journal-title":"Oral Oncol. Rep."},{"key":"61752_CR30","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz, R. A. et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J. Clin. Oncol. 36, 1443\u20131453 (2018).","journal-title":"J. Clin. Oncol."},{"key":"61752_CR31","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld, A. G. et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 52, e56\u2013e93 (2011).","journal-title":"Clin Infect Dis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61752-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61752-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61752-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:46:59Z","timestamp":1791766019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61752-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61752"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61752-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"BioGaia provided the L. reuteri lozenges free of charge; however, none of the authors received research funding, honoraria, lecture fees, consulting fees, or any other payments from the company. The authors have no other conflicts of interest related to this study to declare.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Hiroshima University Certified Review Board (approval number: CRB2020-2005). Informed consent procedures were performed in accordance with the institutional ethical guidelines and the Declaration of Helsinki. Personal information was anonymized and managed appropriately. The study was explained to all participants using written information, and written informed consent was obtained. This trial was registered in the Japan Registry of Clinical Trials (jRCT; registration number: jRCTs061210028) on August 3, 2021.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31849"}}